We present the case of a 21-year-old male patient who underwent primary anterior cruciate ligament (ACL) reconstruction, which was later complicated by retear, deep infection, and massive bone loss. We…
WASHINGTON — Patients with inflammatory arthritis who receive rituximab, interleukin-6 inhibition or Janus kinase inhibitors demonstrate higher severe infection risks vs. TNF inhibitors, according to…
The latest news from the ACR Annual Meeting, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
This popular course is back with a programme packed full of core skills content for all rheumatology professionals. It’s the perfect opportunity to get the…
Corinna Elling-Audersch introduces the EULAR Stene Prize 2025 Topic: “Growing up with an RMD – learning, transitioning from paediatrics and the impacts on ch…
Background/Purpose: VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, first described in 2020, is an autoinflammatory condition characterized by somatic mutations in the UBA1 gene.…
Welcome to “ACR Journals on Air,” the ACR’s newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals. Join us…
Your browser is currently set to block cookies. You need to allow cookies to use this service. Cookies are small text files stored on your…
Background/Purpose: VEXAS syndrome is an autoinflammatory disorder caused by a mutation in the UBA1 gene, which leads to a heterogeneous clinical presentation and progressive bone…
